Company Beacon Pharmaceuticals PLC

BEACONPHAR

BD0482BECON5

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 15/09/2024			5-day change	1st Jan Change
134.10 ^BDT	-2.12%		+17.73%	-45.27%

16/05	Beacon Pharmaceuticals PLC Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
13/02	Beacon Pharmaceuticals PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Business description: Beacon Pharmaceuticals PLC

Beacon Pharmaceuticals PLC, formerly Beacon Pharmaceuticals Limited, is a Bangladesh-based pharmaceutical company. The Company is engaged in the manufacturing and marketing of pharmaceutical finished formulation products and lifesaving Intravenous (I.V) fluids, active pharmaceuticals ingredients, biotech products and genetic engineering products which it sells in the local markets as well as the international markets. The Company also provides contract manufacturing and tool manufacturing services. Its products are focused on various drugs, such as anticancer, cardiovascular, gastrointestinal, antibiotics, anti-coagulants, protein supplements, muscle relaxant, antihistamine, analgesics, and non-steroidal anti-inflammatory drugs (NSAIDS), among others. The Company's product categories include general, oncology, anti-viral and biotech. Its products include Favipiravir, Remdisivir INN, Meropenem, Bendamustine, Bleomycin Sulfate, Daunorubicin, Gemcitabine, Darbepoetin alfa and Filgrastim.

Number of employees: 3,872

Sales by Activity: Beacon Pharmaceuticals PLC

Fiscal Period: June	2019	2020	2021	2022	2023
Pharmaceuticals	464.69Cr	559.08Cr	712.12Cr	802.27Cr	850.99Cr

See all business segments

Geographical breakdown of sales: Beacon Pharmaceuticals PLC

Fiscal Period: June	2019	2020	2021	2022	2023
Bangladesh	441.21Cr	559.08Cr	712.12Cr	802.27Cr	850.99Cr
Export	23Cr	-	-	-	-

See all geographic segments

Managers: Beacon Pharmaceuticals PLC

Director	Title	Age	Since
Mohammed Ebadul Karim CEO	Chief Executive Officer	67	12/01/12
Mohammed Jalal Uddin DFI	Director of Finance/CFO	-	-
Anisur Rahman Khan ADM	Chief Administrative Officer	-	-
Sheikh Mohammad Islam CTO	Chief Tech/Sci/R&D Officer	-	15/08/15
Mohammed Abdul Sarder AUD	Comptroller/Controller/Auditor	-	-

See BEACON PHARMACEUTICALS PLC governance

Members of the board: Beacon Pharmaceuticals PLC

Manager	Title	Age	Since
Mohammed Ebadul Karim CEO	Chief Executive Officer	67	12/01/12
Nurun Nahar Karim CHM	Chairman	65	-
Mohammed Niazul Karim BRD	Director/Board Member	40	-
Mohammad Anwar Hussain BRD	Director/Board Member	-	-

Composition of the Board of Directors

Shareholders: Beacon Pharmaceuticals PLC

Name	Equities	%	Valuation
Mohammed Ebadul Karim 25.21 %	58,228,800	25.21 %	58 M BDT
Mohammed Niazul Karim 2.751 %	6,354,000	2.751 %	6 M BDT
Nurun Nahar Karim 2.045 %	4,725,000	2.045 %	5 M BDT

List of BEACON PHARMACEUTICALS PLC shareholders

Company details: Beacon Pharmaceuticals PLC

Beacon Pharmaceuticals Plc

9/B/2, Toyenbee Circular Road Motijheel C/A

1223, Dhaka

http://www.beaconpharma.com.bd

address Beacon Pharmaceuticals PLC(BEACONPHAR)

Generic Pharmaceuticals

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
BEACON PHARMACEUTICALS PLC	-2.12%	+17.73%	-45.27%	-39.32%	26Cr
SUN PHARMACEUTICAL INDUSTRIES LTD.	+0.17%	+2.43%	+62.60%	+138.92%	5.33TCr
OTSUKA HOLDINGS CO., LTD.	+0.25%	-1.37%	+44.42%	+64.47%	3.09TCr
SANDOZ GROUP AG	-0.40%	-2.63%	-	-	1.76TCr
CIPLA LIMITED	+0.75%	+3.19%	+34.76%	+75.24%	1.6TCr
ZYDUS LIFESCIENCES LIMITED	-0.44%	+0.62%	+72.67%	+96.80%	1.34TCr
THE MEDICINES COMPANY	-.--%	+0.14%	-	-	678.76Cr
ONO PHARMACEUTICAL CO., LTD.	-0.03%	-1.70%	-34.79%	-29.41%	637.53Cr
GLENMARK PHARMACEUTICALS LIMITED	-1.63%	+0.52%	+101.16%	+219.95%	586.04Cr
STADA ARZNEIMITTEL	-.--%	-1.95%	-	-	572.55Cr
Average	-0.35%	+0.27%	+33.65%	+75.24%	1.56TCr
Weighted average by Cap.	+0.04%	+0.18%	+52.33%	+103.02%